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Abstract 
Introduction: The rise in non–communicable diseases (NCDs) has gained increasing attention. There is a great need for reliable data to 
DGGUHVVVXFKSUREOHPV+HUHZHGHVFULEHWKHGHYHORSPHQWRIDFRPSUHKHQVLYHVHWRIH[HFXWLYHDQGVFLHQWL¿FSURWRFROVDQGLQVWUXFWLRQV
of STEPs 2016.
Methods/Design:7KLV LV D ODUJH±VFDOH FURVV±VHFWLRQDO VWXG\RI6XUYHLOODQFHRI5LVN)DFWRUVRI1&'V LQ ,UDQ7KURXJK V\VWHPDWLF
proportional to size cluster random sampling, 31,050 participants enrolled in three sequential processes, of completing questionnaires; 
physical measurements, and lab assessment.
Results:2XWRIGLVWULFWVVDPSOHVZHUHWDNHQIURPXUEDQDQGUXUDODUHDVRIGLVWULFWV$IWHUDSSO\LQJVDPSOLQJZHLJKW WR WKH
VDPSOHVFRPSDULQJWKHGLVWULEXWLRQRISRSXODWLRQDQGVDPSOHVFRPSDUHGFODVVL¿FDWLRQZDVGHWHUPLQHGLQDFFRUGDQFHZLWKWKHDJHDQGVH[
groups. Out of 31,050 expected participants, 30,541 participant completed questionnaires (52.31% female). For physical measurements 
DQGODEDVVHVVPHQWWKHFDVHVLQFOXGHGIHPDOHDQGIHPDOHUHVSHFWLYHO\
Discussion: 7KHUHLVDQXUJHQWQHHGWRIRFXVRQUHYLHZLQJWUHQGDQDO\VHVRI1&'V7RWKHEHVWRIRXUNQRZOHGJHWKHSUHVHQWVWXG\LVWKH
¿UVWFRPSUHKHQVLYHH[SHULHQFHRQV\VWHPDWLFHOHFWURQLFQDWLRQDOVXUYH\7KHUHVXOWVFRXOGEHDOVRXVHGIRUIXWXUHFRPSOHPHQWDU\VWXGLHV
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Introduction
The aging population and the increase in level of exposure to risk factors for non–communicable diseases (NCDs) have 
raised in the burden of NCDs in the last three decades.1–3 
The slope of changes is steeper in the developing countries.2–6 In 
developed and especially developing countries, policymakers in 
the health sector need to have access to reliable information on the 
level and trends of exposures to NCDs risk factors.2,7 The WHO 
recommended a comprehensive commitment for reducing 25% of 
unconditional probability of deaths for four major NCDs of 
Cardiovascular Diseases (CVDs), Diabetes, Cancers and Chronic 
Respiratory Diseases through reduction in tobacco use, unhealthy 
diet, lack of physical activity and harmful alcohol use by 2025, 
which urges countries to be aware of the distribution of NCDs risk 
factors exposures.8 
However, limited reliable information on the distribution 
of NCDs risk factors exposures remains a major concern for 
policymakers in the developing countries.9–11 The concern gets 
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higher attentions in Iran considering its NCDs action plan and 
ambition to estimate NCDs risk factors distribution at the sub–
national levels.7,11–14
The WHO STEPwise approach to risk factor Surveillance, the 
so–called STEPs, provides a simple, standardized method for 
collecting, analyzing and disseminating relevant information helps 
countries to build and strengthen their capacity for conducting 
surveillance.15 
The instruments of STEPs 2016 in Iran cover three different 
levels of assessment: step 1) demographic, epidemiologic, 
and risk–related behavioral information; step 2) physical 
measurements; and step 3) lab measurements of a nationally 
representative sample of Iranian adults. 
The STEPs surveys have been implemented in Iran in 2005, 
2006, 2007, 2008, 2009 and 2011. In all of these surveys, the 
WZR ¿VW VWHSV KDYH EHHQ FRQGXFWHG ,Q   , lab 
measurements were included as the third part of the survey.16,17
Despite numerous strengths, previous STEPs as the only 
complete reliable national data sources, suffer from several 
shortcomings. For  instance, considerable challenges were faced 
in cleaning the data because of the change in the content of 
questions and non–standardized coding processes.13,17 The missing 
data and implausible ranges were other important problems that 
mostly derived from using paper questionnaires and manual data 
entry. Also, some uncertainty comes from variations of sampling 
method in different surveys.18–20 
Considering these facts, a purposeful attempt, with maximum 
enjoyment of the opinions of experts and key informants, was made 
to design the comprehensive set of administrative and supervisory 
protocols for the STEPs 2016. In this paper, we describe how we 
GHYHORSDFRPSUHKHQVLYHVHWRIH[HFXWLYHDQGVFLHQWL¿FSURWRFROV
and instructions that meet the needs of the survey.
Methods/Design
Using peer discussion interaction method, a set of complex 
processes of expert peer review were resumed to integrate the 
VFLHQWL¿F UHFRPPHQGDWLRQV IRU HDFK RI WKH LQVWUXFWLRQV DQG
complementary documents. 
These processes were followed by iterated drafting of protocol 
VSHFL¿FDWLRQVDQGSLORWWHVWV$OVRDVDODUJHVFDOHQDWLRQDOVXUYH\
the feasibility of conducting was evaluated in association with 
implementation in a national–level scale. In all these reviews, 
we focused on the survey objective as the main conveniences of 
project which is determining the prevalence of main preventable 
risk factors of NCDs in Iran (including smoking, poor nutrition, 
low physical activity, high blood pressure, overweight and obesity, 
high blood glucose, and high blood lipids) by age and sex groups.
Processes of implementation
Based on the comprehensive study on the six rounds of 
implementation of STEPs in Iran and considering other countries’ 
H[SHULHQFHV WKH UHTXLUHG VSHFL¿FDWLRQV IRU RXWFRPHV DQDO\VLV
ZHUH WUDQVIHUUHG WR FRPSUHKHQVLYH VWXG\ SURWRFRO VSHFL¿FDWLRQ
procedures.
After development of protocols that cover several areas 
(including information technology,  questionnaire and guide for 
interviewers, physical measurements, laboratory measurement 
and Bio–banking, capacity building and training, supervision, 
sampling, feasibility assessment, statistical analyses and ethical 
consideration), by the Non–Communicable Diseases Research 
Center of Endocrinology and Metabolism Research Institute 
of Tehran University of Medical Sciences, all documents were 
GLVWULEXWHG DPRQJ WKHPHPEHUV RI WKH VFLHQWL¿F FRPPLWWHH IRU
WKHLU¿QDOFRPPHQWVDQGDJUHHPHQWV
Information Technology Protocols 
To accelerate and facilitate the implementation of the processes 
and to increase and improve the accuracy of data registration 
DQG WUDQVPLVVLRQ ZH GHYHORSHG D VSHFL¿F SURWRFRO EDVHG RQ
Information Technology (IT) standards and guidelines. Moreover, 
we included many measures to control the quality and optimize the 
management of processes which were entirely run and managed 
in a web–based fashion.20–23
This comprehensive protocol contains three specialized tasks 
of Android Application for data gathering, Web-based dashboard 
for reporting and monitoring, and Windows-based application 
for Laboratory Information Management System (LIMS). For 
importing questions and base data into database, we developed a 
third party application that reads tagged questionnaire and imports 
related data to database faster.24,25
All communications between all Android tablets and the server 
use HTTPS protocol and all communications between tablets and 
servers are based on JSON technology. We used Apache Tomcat 
web service with related web methods for middle interpreter 
between Android tables and SQL server database. For better 
performance in communication between Android tablets and web 
VHUYLFH ORZHULQJ VHUYHU QHWZRUN WUDI¿F DQG EHWWHU FRPSUHVV±
decompress data, JAVA-based web service was used.2,21,25          
,Q WKLV SDUW ZH SURYLGH D EULHI GHVFULSWLRQ RI VFLHQWL¿F DQG
executive protocols and instructions that were enrolled in 
implementing Iran STEPs 2016:
All three sequential processes of starting with gathering 
information on key risk factors by the use of questionnaires (Step 1), 
physical measurements (Step 2), and lab assessment (Step 3) were 
completely assessed and developed based on standard requirement 
of reliable national survey.22,24
Questionnaire and guide for interviewers
Considering the questionnaires which were used in 2005, 
2006, 2007, 2008, 2009, 2011, after revision of some topics, 
evaluation of questions’ consistency  and assessment of validity 
and reliability, a practical version of the questionnaire have been 
developed in which demographic, behavioral information (e.g. 
nutrition, physical activity, smoking and alcohol consumption), 
history of metabolic risk factors and injuries, health care 
utilization, screening programs and treatment are targeted as 
WKHPDLQLQWHUHVWV7KH¿QDODSSURYHGYHUVLRQKDVEHHQXVHGIRU
digitalization of data gathering.
Physical measurements protocol 
Through expert panels and consistent with WHO protocols and 
aligned with previous round of study, these instructions contain 
standards for measurement of anthropometric variables, blood 
pressure, pulse rate, and individuals’ pedometer information. 
We also standardized details of calibration for both tools and 
measurement processes. For this purpose, a total of 572 tablets 
/HQRYR $  VFDOHV ,QR¿W  EORRG SUHVVXUH
measuring devices (Beurer), 261 height measuring instruments 
and 220 pedometers (Xiaomi) were prepared and distributed.
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Laboratory measurement and Bio–banking 
We aimed to store the biological samples that will be randomly 
collected from all provinces (city/village) of Iran. Using the auto 
analyzer (Cobas C311 Hitachi High–Technologies Corporation. 
Tokyo Made in Japan) approved by Health Reference Laboratory, 
the levels of Total Cholesterol, Glucose, HDL–C, ALT, and 
Triglyceride were assessed from the plasma. Moreover, for all 
participants, HbA1c of whole blood was measured. The urine 
tests included sodium (Na) and creatinine (Cr) measurements.
To evaluate the validity of urine Na, the 24–hour urinary 
excretion of Na was assessed in a sub-sample of 550 participants 
randomly selected from all over the country. In order to the assess 
the accuracy of 24–hour urine collection, following detailed 
explanations and the require process for informed consent, using 
Potassium Amino Benzoic Acid (POTABA) tablets, over recorded 
KRXUVXULQHZDVFROOHFWHGLQVSHFL¿FSURYLGHGFRQWDLQHU
7KHVHDUHWKH¿UVWVWRUHGVDPSOHVWKDWDUHUHSUHVHQWDWLYHRIWKH
Iranian population. In this project, the bio–banking of biological 
samples (e. g. blood, plasma, buffy coat and DNA) collected from 
20560 participants will be set to support the modern research 
directions in medicine such as omics (Genomics, Transcriptomics, 
Proteomics, and Metabolomics) and personalized medicine.26–28
Temperature and transport requirements
Maintaining the optimal conditions for the transfer of biological 
samples using the updated standards for promotion of quality 
of biological samples and biomolecules maintenance, we 
developed the comprehensive participatory protocol and related 
instructions.29,30
Blood and urine sample collection and transport were performed 
DWDWHPSHUDWXUH&8VLQJVSHFL¿FGHVLJQHGSDFNDJHLQFOXGLQJ
¿YHWXEHVFRQWDLQLQJZKROHEORRGFFEXII\FRDWFFSODVPD
REWDLQHG IURP WXEH FRQWDLQLQJ VRGLXP ÀXRULGH  FF SODVPD
obtained from tube containing lithium heparin (3 cc) and urine (6 
cc), the gathered biological samples were transferred to the central 
processing/archiving laboratory of study in NCDRC. Through a 
detailed time-binding action plan, the processes from collection to 
the central processing/archiving lab were managed in the shortest 
time (less than 18 hours).
All samples were transported in vaccine transport boxes. During 
transportation, in each cold box, a digital thermometer recorded 
the temperature of environment of the biological sample. These 
enable us to keep biological samples from freezing/ thawing. 
Instructions and Packages for Capacity Building and Training
There is also a comprehensive package of hierarchical training 
steps in different levels of study partners. These documents 
contain curricula and educational materials which are prepared 
IRUDOOVWHSVRIVFLHQWL¿FDQGH[HFXWLYHSURFHVVHV
Training was managed in two levels of national and provincial, 
as Training of Trainers (TOT) model. 
0DQ\VSHFL¿FWUDLQLQJFRXUVHVZHUHFRQGXFWHGIRUDOORIWHDPV
at two executive levels of universities and cities. The trainers were 
VHOHFWHGIURPH[SHUWVRI1&'V¿HOGRIPHGLFDOXQLYHUVLWLHVDQGWKH
accreditation approvals for all of co–researchers were approved 
through online evaluations. In total, during the training process, 
LQHDFKVSHFL¿FGRPDLQDWQDWLRQDOOHYHODERXWH[SHUWVZHUH
trained as trainers for sub–national training. At provincial level, 
more than 1500 individuals participated in training programs.
Supervision protocol
For supervising the STEPs 2016, we used national and sub–
national monitoring and supervising plan to be done before, 
during, and after the survey conduction. Based on supervising 
standards, before the program, the infrastructures, preparedness 
and training courses were monitored by a group of experts in 
Ministry of Health and Medical Education (MOHME). 
During the implementation, at the same time, better monitoring 
was achieved through three paths of quality control including 1) 
completing the key–questions in a sub–sample of individuals; 
2) ongoing online controlling of recorded date and 3) direct 
REVHUYDWLRQRILQWHUYLHZVE\¿HOGYLVLW
$IWHU ¿QLVKLQJ WKH SURJUDP DOO UHFRUGHG GDWD UHYLHZLQJ DQG
the possible missed data were repaired by direct contact with 
SDUWLFLSDQWVYLD IHHG±EDFN WRSURYLQFLDO VWDIIV LQ¿HOGV)LQDOO\
WKH UHVXOWV ZHUH DVVHVVHG E\ VFLHQWL¿F FRPPLWWHH RI SURJUDP
held in NCDRC, MOHME, and National Institute For Health 
Researches (NIHR).
Sampling protocol
For proportional to size sampling, we designed a systematic 
cluster random sampling frame through which 31,050 participants 
(3105 clusters) were selected from urban and rural areas of 31 
provinces of Iran. To estimate the minimum sample at the 95% 
FRQ¿GHQFH OHYHO WKH PRVW VSDUVHO\ SRSXODWHG SURYLQFH RI WKH
country with 384 samples (Ilam) was considered as the basis of 
calculations. The sample size of other provinces was calculated 
Figure 1. Electronic questionnaire
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according to the population ratio of each to the referenced 
province. To consider the effect of sampling design and to control 
non–response error, 10% was added to the estimated samples 
of each province. With a view to reducing costs and increasing 
productivity, it was decided that for provinces with 800 or more 
samples through weighting methods, half of calculated sample 
size taken along with the twice weight in estimating.22,31–33 
In this regard, national individual ID and postal code were used 
as part of individual characteristics in the questionnaire that has to 
be validated by interviewer through seeing national ID card.
7KHHOLJLEOHSRSXODWLRQIRUVWXG\ZDVGH¿QHGDFFRUGLQJWRWKH
FULWHULDRIEHLQJDPRQJ\HDUVROG,UDQLDQDGXOWVWKDWUHVLGHG
LQ,UDQDWWKHWLPHRIGDWDFROOHFWLRQ7KH¿UVWDQGVHFRQGVWHSV
of study have been run for all selected samples and the third 
VWHSZDVFRQVLGHUHGIRUWKRVHZKRZHUH\HDUVRIDJH'DWD
were collected from individuals who agreed to participate and 
completed inform consent forms. The software features enabled 
us to analyze non–participation in each of study steps. 
Feasibility assessment and simulation
The feasibility of the protocol and probable power points and 
shortcomings of study were examined by a feasibility study 
which simulated all executive parts in a real implementation of 
the project in a simulated study. The results of this phase provide 
us with a better conception of executive details and more revision, 
especially concerning software. 
Statistical analyses 
7KHGDWDDUH¿UVWXVHG IRUSUHVHQWLQJ WKHGHVFULSWLYHVWDWLVWLFV
of interested variables, by sex and age subgroups at national and 
sub–national levels. Moreover, the provincial estimation, the 
VSHFL¿FDWLRQVRIJHRJUDSKLFDOGDWDVDPSOLQJHQDEOHXVWRSURYLGH
the interest outcomes in small area levels. Data can be also used 
for association between subgroup variables and can be included as 
a main component of trend analysis in comprehensive researches.
In order to achieve a representative sample of Iranian target 
population, exact weights were calculated, consisting of provincial 
weight (province with more than 800 sample size get weight 2), 
Figure 2.3URFHVVHVRIODERUDWRU\PHDVXUHPHQWDQG%LR±EDQNLQJ
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sampling weight (each subject in sample is representation of 
VHYHUDOSHRSOHVLQJHQHUDOSRSXODWLRQWKUHHZHLJKWVVSHFL¿FIRU
each steps (for individual who did not participate in that step), 
same age–sex group weight (we only enter one person from two 
individuals who were in same age–sex group in a household), 
householder weight (it was necessary to include householder as 
WKH ¿UVW VDPSOH LQ HDFK KRXVHKROG DQG ¿QDOO\ QRQ±UHVSRQVH
weight (for persons who did not participate in the study).
Ethical considerations
Ethical approval for the study was obtained from the 
Ethical Committee of National Institute for Medical Research 
Development (NIMAD) (ID:IR.NIMAD.REC.1394.032). 
Participation in the study was voluntary. Regarding moral 
consideration, the objectives and methods of the study were 
described for all of eligible individuals and written informed 
consent was obtained from all those who accepted to participate. 
For those who participated in the 24–hour urine collection test, 
a complementary informed consent process was undertaken, 
containing all required processes and explanation on Potassium 
Amino Benzoic Acid (POTABA) test.   
Results
%DVHGRQ WKH VSHFL¿FDWLRQRIGHVLJQDQG VDPSOLQJ IUDPH WKH
present survey provides the maximum extent for estimation of 
levels of prevalence of NCDs risk factors and diseases. In STEPs 
2016, out of 429 Iranian districts, samples were taken from urban 
and rural areas of 389 districts (Figure 3).
As another point through comprehensive efforts to engage 
individuals to participate in the study, only ten provinces did not 
achieve the full estimated samples, nine of which had more than 
99% achieved percentage. Qom province refused to participate in 
the study (Figure 4). 
After applying sampling weight to the samples, comparing the 
distribution of population and samples, Kolmogorov–Smirnov 
WHVWZDVSHUIRUPHGDQGFRPSDUHGFODVVL¿FDWLRQZDVGHWHUPLQHG
in accordance with the age and sex groups. Probability sample 
tests showed that the study population is representative at the 
national and provincial levels.
Out of 31,050 expected participants, 30,541 participant 
completed questionnaires Step 1, of whom 52.31% were female. 
For physical measurements and lab assessment, the cases 
included 30,042 (52.38% female) and 19,778 (54.04% female), 
Figure 3. The distribution of sampling point according to residential areas
Archives of Iranian Medicine, Volume 20, Number 9, September 2017 613
S. Djalalinia, M. Modirian, A. Sheidaei, et al.
respectively (Table 1). There were also some differences between 
participation rate in urban and rural areas (Figure 5).
Totally, 9048 (29.63%) of samples were in rural areas. On the 
other hand, 8886 (29.58%) and 6965 (35.22%) of participants for 
physical measurements and lab assessment, respectively, were 
living in rural areas.
Discussion
The United Nations (UN) and the World Health Organization 
(WHO), in comparison with mortality in 2010, have called for a 
25% reduction in mortality from NCDs in age groups of 30 – 70 
years old, by 2025, adopting the slogan “25 by 25”.6 In addition, at 
WKHVDPHWLPH,UDQKDVFRPPLWWHGWRVSHFL¿FDWWHQWLRQRQ1&'V
to comply by the commitments of Sustainable Development 
Goals (SDGs).6,7
In order to achieve these goals, one of the effective strategies 
focuses on public health interventions.32,33 In order to plan and 
conduct these interventions, we need an exact vision of distribution 
of metabolic risk factors and life style that could be provide 
through STEPs. Thus, STEPs 2016 could be used as the accurate 
basis of evidence-based interventional programs of health system 
and better policy making for NCDs.
In order to develop administrative and supervisory protocols for 
WKH67(3VZH WRRNDGYDQWDJHRI WKH VFLHQWL¿F UHVRXUFHV
of academic partnerships and analytical results of previous six 
rounds of the implementation of this national survey in Iran. 16–18 
In addition, considering the importance of consistency between 
questions, studied topics, indices, and the corresponding options, 
ZHXWLOL]HGUHOHYDQWVWUDWHJLHVIRUGUDZLQJRSWLPXPEHQH¿WIURP
the collected information. 15,18
The valuable experiences of six rounds of implementation 
of STEPs in Iran have yielded many noticeable strengths and 
improvements. One of the most important features of this survey is 
its continuous nature. Considering the national capacities such as 
UXUDOSULPDU\KHDOWK±FDUHZRUNHUVDQGEHQH¿WLQJIURPUHFRXUVH
mobilization for better health, awareness of trends of metabolic 
and lifestyle risk factors in planning for control and prevention of 
NCDs is crucial. 34 –36  Although over time, methods and contents 
of STEPs have not remained untouched, the overall consistency 
Age groups
4XHVWLRQQDLUHV6WHS 3K\VLFDOPHDVXUHPHQWV6WHS /DEDVVHVVPHQW6WHS
Male Female Male Female Male Female
18–24 1261 1542 1242 1520 - - - - - -
25–34 3426 3865 3360 3801 2085 2671
35–44 3137 3358 3078 3310 2125 2571
45–54 2638 2935 2593 2892 1879 2257
55–64 2100 2279 2062 2240 1551 1743
65–69 647 791 631 779 450 573
 1357 1205 1341 1193 1000 873
Total 14566    9090 10688
Table 1. The distribution of study participants according to study steps, sex, age groups, at national level
Figure 4. The distribution of achieved percent in cluster sampling
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(mostly on contents rather methods) would be a strong point 
of STEPs over years.18 Considering a vast variety of exposures 
and outcomes at sub–national level, providing provincially 
representative data is undoubtedly the most important privilege 
of STEPs. In the last round of STEPs in 2011, the questionnaire’s 
scope has been extended to outcomes questions. 
Despite previous considerable efforts, there are noticeable gaps 
and limitations that have been considered in revision of protocols 
and instructions. Incomprehensiveness and missing components 
of previous STEPs regarding many critical NCDs risk factors, lack 
of long term strategic approach for proceeding STEPs, analytical 
limitation due to sampling issues and lack of cost orientated 
approaches in design and conduction, were carefully addressed in 
this round of implementation. 
One of the main strengths of this comprehensive protocol is its 
focus on the standards and regulatory guidelines which had been 
proposed in the form of a comprehensive package. This package 
includes all regulatory standards designed for all stages and levels 
of the study. The aim of monitoring all phases of the study focused 
on identifying shortcomings and challenges and making qualitative 
and quantitative improvements in the implementation of the study 
at the national, provincial, and district levels at different stages, 
i.e. before, during, and after the implementation of the plan. For 
WKDWUHDVRQWKHSDFNDJHGH¿QHVDQGFODUL¿HVDOOWKHVWDNHKROGHUV¶
different responsibilities, corresponding measures, operational 
processes, tools, strategies, and expected outcomes. Using a wide 
communication network (Telephone, SMS, and Virtual Networks 
“Telegram”) and the secure communication platform (HTTPS) 
IRUGDWDWUDQVIRUPDWLRQZHUHRWKHUVSHFL¿FDWLRQRI67(3V
$OO WKHVHFRQVLGHUDWLRQDUH WDNHQ LQWRDFFRXQW IRU WKH¿UVW WLPH
(Table 2).
We also faced some limitations. Despite our attempts to recourse 
Figure 5. The distribution of study participants according to study steps and residence area, at provincial level
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mobilization and partnership, there were many limitations in these 
regards. On the other hand, integrated digitalized data recording, 
DWWKH¿UVWFRPSUHKHQVLYHQDWLRQDOVFDOHUHTXLUHGVSHFL¿FWUDLQLQJ
and exact ongoing follow–up that lead to time consuming activities 
for the core team.
In conclusion, to the best of our knowledge, the present study 
LV WKH¿UVW FRPSUHKHQVLYH H[SHULHQFHRQ V\VWHPDWLFGHVLJQ DQG
conduction of fully digitalized national survey. Considering the 
evidence on national requirements for promotion of STEPs survey, 
ZH GHYHORSHG D FRPSUHKHQVLYH VHW RI H[HFXWLYH DQG VFLHQWL¿F
protocols and instructions that meet the needs of standard national 
survey. The results could be also used for future complementary 
studies.
We should focus on reviewing trends analyses of NCDs, 
clarifying the time priorities of interventions and strategic plan 
RIUHTXLUHGLPPHGLDWH LQWHUYHQWLRQ,Q WKHQH[WVWHSEHQH¿WWLQJ
from maximum participation of specialists and all stakeholders, 
a comprehensive plan must be developed for specialized 
interventions in each of these areas of lifestyle and metabolic risk 
factors.
National and sub–national comprehensive action plans are 
required to target the prevention and control of NCDs and injuries 
in Iran. Considering the previous experiences and lessons learned 
from other countries’ success could be used for design and 
implementation of interventions.
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Design Implementation
Sampling 
z Proportional to Size Sample Size
z Systematic Random Sampling
z Possibility of determining Risk Factor Map in 
megacities
z National individual and postal codes used as a part of individual characteristics in the questionnaire 
that has to be validated by interviewer through seeing national ID card
z All of sampling methods run through software random selection with the remove the questioner error
z Aim to reduction non-response preventive strategies have been considered in software development
z Determining the time and Place of Interviewing via GPS
z Designing integrated soft wares by NCDRC’s staffs
First step
z Maximum effort to revision and development of 
questions and information forms based on national 
objectives, local requirement and consistent with World 
Health Organization standards
z Eliminating of Error in Data Entry
z Whole Digitalized Study
z Whole Online Study
z Data gathering by Tablets
z Participating of Administrative Teams in Online Exam
z Online sending of supervision checklists ‘data 
Second step
z 'HYHORSPHQWRIVSHFL¿FFRPSUHKHQVLYHLQVWUXFWLRQ
for anthropometric measures 
z Data gathering of daily individuals’ steps 
z Validity assessment of physical activity data
z %HQH¿WLQJIURPVWDQGDUGL]HGFDOLEUDWHGPHDVXUHPHQW
z Unique brands of all equipment
z Pedometer for Sub-samples
z Monitoring of measurement process ( different levels supervision and quality control consideration)
z Participating of Administrative Teams in Online Exam
z Data gathering by Tablets
z Online sending of supervision checklists ‘data 
Third step 
z New added components to protocol
z HbA1c Test for All Samples
z ALT Test for All Samples
z Urine-Na Test for All Samples
z 24h Urine Sample (POTAPA) for Sub-samples 
z Comprehensive training programs for target groups
z Designing Special Educational Films for Interviewers 
and Lab Experts
z Designing Special Educational Films for digitalized 
data gathering processed
z Data gathering by Tablets
z All Lab exams by unique brands of devices and kits
z Holder and Vacuum Tubes for Blood Sampling
z Unique Brands of All Sphygmomanometers, Scales, Lab Tubes, SIM Cards, and the Other 
Equipment
z Secure Methods for Transporting the Biologic Samples
z Unique and Special Boxes for Transmission of Samples
z Equipping a Unique Bio bank 
z Unique Tubes for every sample Using Designed Barcodes
z Participating of Administrative Teams In Online Exam
z 'HVLJQLQJVSHFLDOHGXFDWLRQDO¿OPVIRULQWHUYLHZHUVDQGODEH[SHUWV
z Online sending of supervision checklists ‘data
Table 2. 7KHVSHFL¿FDWLRQVRI67(3V
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